Open access · CC-BY
via OpenAlex
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Journal of Molecular Neuroscience · 2017 · ▲ 54 citations
Abstract
Parkinson's disease (PD) is a progressive brain disorder that interferes with activities of normal life. The main pathological feature of this disease is the loss of more than 80% of dopamine-producing neurons in the substantia nigra (SN). Dopaminergic neuronal cell death occurs when intraneuronal, insoluble, aggregated proteins start to form Lewy bodies (LBs), the most important component of which is a protein called α-synuclein (α-syn). α-Syn structurally contains hexameric repeats of 11 amino acids, which are characteristic of apolipoproteins and thus α-syn can also be considered an apolipoprotein. Moreover, apolipoproteins seem to be involved in the incidence and development of PD. Some apolipoproteins such as ApoD have a neuroprotective role in the brain. In PD, apoD levels increase in glial cells surrounding dopaminergic cells. However, elevated levels of some other apolipoproteins such as ApaA1 and ApoE are reported as a vulnerability factor of PD. At present, when a clinical diagnosis of PD is made, based on symptoms such as shaking, stiff muscles and slow movement, serious damage has already been done to nerve cells of the SN. The diagnosis of PD in its earlier stages, before this irreversible damage, would be of enormous benefit for future treatment strategies designed to slow or halt the progression of PD. This review presents the roles of apolipoproteins and α-syn in PD and how some of them could potentially be used as biomarkers for PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s12031-017-0942-9
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Emamzadeh, F.N. (2017). Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease. <em>Journal of Molecular Neuroscience</em>. https://doi.org/10.1007/s12031-017-0942-9
Vancouver
Emamzadeh FN. Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease. Journal of Molecular Neuroscience. 2017. doi:10.1007/s12031-017-0942-9.
BibTeX
@article{fatemeh2017Roleof,
title = {Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease},
author = {Fatemeh Nouri Emamzadeh},
journal = {Journal of Molecular Neuroscience},
year = {2017},
doi = {10.1007/s12031-017-0942-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Aging Neuroscience 2021
Open access · CC-BY
Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
Aging Cell 2004
Citation only
How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes
Sleep Medicine Reviews 2016
Preprint · OA
Chronotype and circadian rhythm in bipolar disorder: A systematic review
PLoS ONE 2012
Open access · CC-BY
The Role of Alpha-Synuclein Oligomerization and Aggregation in Cellular and Animal Models of Parkinson’s Disease
International Journal of Molecular Sciences 2021
Open access · CC-BY
Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson’s Disease
Biomolecules 2015
Open access · CC-BY